Ali Bilal

Ali Bilal is an experienced professional in the pharmaceutical industry, currently serving as a Managing Shareholder at Amgen since 2018, where they oversee product strategy and execution in global markets. Previously, Ali held the position of Global Product Director at Genentech from 2015 to 2018, leading multinational teams to ensure market success. Ali's career began with a role as a Clinical Research Associate, where they contributed to a significant clinical trial for a new diabetes drug. They earned a Bachelor of Business Administration from the University of Washington and a Master of Business Administration from MIT Sloan School of Management.